Fibrin fragment D-dimer and the risk of future venous thrombosis.

Plasma D-dimer concentration rises more than 100-fold during acute deep vein thrombosis, but there are no prospective data concerning D-dimer as a risk factor for incident venous thrombosis in a general population. Incident venous thrombosis was ascertained in 2 prospective observational studies, the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study. Of 21 690 participants enrolled between 1987 and 1993, after 8 years of follow-up, D-dimer was measured using baseline stored plasma of 307 participants who developed venous thrombosis and 616 who did not. Relative to the first quintile of the distribution of D-dimer, the age-adjusted odds ratios for future venous thrombosis for the second to fifth quintiles of D-dimer were 1.6, 2.3, 2.3, and 4.2, respectively (P for trend <.0001). Following added adjustment for sex, race, body mass index, factor V Leiden, prothrombin 20210A, and elevated factor VIII coagulant activity (factor VIII:c), these odds ratios were 1.5, 2.1, 1.9, and 3.0, respectively (P for trend <.0001). Among those with idiopathic thrombosis or secondary thrombosis unrelated to cancer, the adjusted fifth quintile odds ratios were 3.5 and 4.8, respectively. By contrast, D-dimer in the fifth versus first quintile was not related to occurrence of cancer-associated thrombosis (odds ratio, 1.1). Odds ratios for elevated D-dimer were consistently elevated in subgroups defined by age, sex, race, duration of follow-up, and thrombosis type (deep vein thrombosis or pulmonary embolus). D-dimer is strongly and positively related to the occurrence of future venous thrombosis.

[1]  A. Folsom,et al.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. , 2002, Archives of internal medicine.

[2]  T. Spector,et al.  Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state , 2002, The Lancet.

[3]  R. Tracy,et al.  Longitudinal Stability of Coagulation, Fibrinolysis, and Inflammation Factors in Stored Plasma Samples , 2001, Thrombosis and Haemostasis.

[4]  J. Danesh,et al.  Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis , 2001, Circulation.

[5]  V. Salomaa,et al.  Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Hirsh,et al.  Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study , 2001, Thrombosis and Haemostasis.

[7]  A. Perrier Deep vein thrombosis and pulmonary embolism: a single disease entity with different risk factors? , 2000, Chest.

[8]  M. Woodward,et al.  Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged 45-64 Years , 2000, Thrombosis and Haemostasis.

[9]  D. Berry,et al.  Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  G. Lowe,et al.  Prediction of Deep Vein Thrombosis after Elective Hip Replacement Surgery by Preoperative Clinical and Haemostatic Variables: The ECAT DVT Study , 1999, Thrombosis and Haemostasis.

[11]  F. Rosendaal Venous thrombosis: a multicausal disease , 1999, The Lancet.

[12]  A. Sharrett,et al.  Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  L. Kuller,et al.  Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. , 1999, American journal of epidemiology.

[14]  D. Slosman,et al.  Non-invasive diagnosis of venous thromboembolism in outpatients , 1999, The Lancet.

[15]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[16]  P. Mannucci,et al.  Inherited Thrombophilia: Part 1 , 1996, Thrombosis and Haemostasis.

[17]  G. Lowe,et al.  Determinants of fibrin D-dimer in the Edinburgh Artery Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[18]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[19]  P. Ridker,et al.  Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. , 1994, Circulation.

[20]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[21]  C. Edwards,et al.  D‐dimer: A useful marker of disease stage in surgery for colorectal cancer , 1993, The British journal of surgery.

[22]  A. Sharrett The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component. , 1992, Annals of epidemiology.

[23]  M. Prins,et al.  A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. , 1991, Archives of internal medicine.

[24]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[25]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[26]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[27]  P. Mombaerts,et al.  Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis , 1987, Thrombosis and Haemostasis.

[28]  B. Cosmi,et al.  Risk of Venous Thromboembolism Recurrence: High Negative Predictive Value of D-dimer Performed after Oral Anticoagulation Is Stopped , 2002, Thrombosis and Haemostasis.

[29]  F. Rosendaal,et al.  D-Dimer as a Risk Factor for Deep Vein Thrombosis: The Leiden Thrombophilia Study , 2002, Thrombosis and Haemostasis.

[30]  A. Folsom,et al.  CHS/ARIC Manuscript Proposal #708 PC Reviewed: 01/06/00 Status: Approved Priority: 2 SC Reviewed: ________ Status: Approved Priority: 2 1a. Title: Cardiovascular risk factors and venous thromboembolism incidence: The Longitudinal Investigation of Thromboembolism Etiology (LITE) Study b. Abbreviated , 2000 .

[31]  P. Elwood,et al.  Fibrin D-dimer, Tissue Plasminogen Activator, Plasminogen Activator Inhibitor, and the Risk of Major Ischaemic Heart Disease in the Caerphilly Study , 1998, Thrombosis and Haemostasis.

[32]  G. Tofler,et al.  Hemostatic risk factors for cardiovascular disease , 1996 .

[33]  M. Graffar [Modern epidemiology]. , 1971, Bruxelles medical.